Heng Mei Selected Research

Heng Mei Research Topics

Disease

22	Neoplasms (Cancer) 02/2022 - 04/2011
11	COVID-19 05/2022 - 01/2020
11	Thrombosis (Thrombus) 12/2020 - 01/2015
7	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2015
6	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 08/2020
6	Disseminated Intravascular Coagulation 01/2020 - 01/2017
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 08/2011
5	Leukemia 11/2020 - 04/2011
4	Multiple Myeloma 01/2022 - 11/2018
4	Glioma (Gliomas) 01/2021 - 12/2013
3	Inflammation (Inflammations) 02/2022 - 01/2020
3	Thrombocytopenia (Thrombopenia) 01/2022 - 09/2020
3	Hemorrhage 01/2022 - 08/2020
3	Hypoxia (Hypoxemia) 12/2021 - 01/2020
3	Cytokine Release Syndrome 01/2020 - 01/2018
3	Infarction (Infarctions) 06/2018 - 05/2013
2	Sepsis (Septicemia) 02/2022 - 01/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2021
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2021
2	Lymphoma (Lymphomas) 01/2021 - 01/2020
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 10/2012
2	Myocardial Infarction 06/2011 - 01/2009
1	Endotoxemia 02/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Thrombophilia 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Colitis 12/2021
1	Ulcer 12/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Hematuria 01/2021

Drug/Important Bio-Agent (IBA)

10	Chimeric Antigen ReceptorsIBA 01/2022 - 07/2019
8	Pharmaceutical PreparationsIBA 02/2022 - 12/2013
8	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 01/2015
8	Thromboplastin (Tissue Factor)IBA 01/2020 - 10/2012
7	Proteins (Proteins, Gene)FDA Link 12/2021 - 05/2013
6	Inosine Triphosphate (ITP)IBA 01/2022 - 08/2020
5	Paclitaxel (Taxol)FDA LinkGeneric 12/2017 - 12/2013
4	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2008
3	hetrombopagIBA 01/2022 - 01/2021
3	AntigensIBA 01/2022 - 02/2020
3	FibrinIBA 04/2021 - 01/2016
3	Therapeutic UsesIBA 02/2020 - 01/2016
3	polyethylene glycol-poly(lactide-co-glycolide)IBA 01/2020 - 05/2013
2	Thrombopoietin ReceptorsIBA 01/2022 - 01/2021
2	AutoantibodiesIBA 01/2022 - 01/2022
2	Thrombopoietin (c-mpl Ligand)IBA 01/2022 - 12/2021
2	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 07/2016
2	Indicators and Reagents (Reagents)IBA 12/2020 - 04/2011
2	MicellesIBA 08/2020 - 01/2016
2	Oxygen (Dioxygen)IBA 01/2020 - 05/2017
2	CytokinesIBA 01/2020 - 01/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 05/2017
2	enhanced green fluorescent proteinIBA 01/2019 - 01/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2018 - 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 05/2022
1	Simvastatin (Zocor)FDA LinkGeneric 02/2022
1	EndotoxinsIBA 02/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	6-methyladenineIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	N-methyladenosineIBA 01/2022
1	Complement C3a (Complement 3a)IBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Mesalamine (Mesalazine)FDA LinkGeneric 12/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2021
1	HydrogelsIBA 12/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021
1	eltrombopag FDA Link 12/2021
1	PolymersIBA 12/2021
1	Interleukin-4 (Interleukin 4)IBA 10/2021
1	Interleukin-17 (Interleukin 17)IBA 10/2021
1	perforin-granzyme BIBA 10/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021
1	Interleukin-2 (IL2)IBA 10/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2021
1	DNA (Deoxyribonucleic Acid)IBA 08/2021
1	Cisplatin (Platino)FDA LinkGeneric 08/2021
1	Succinic Acid (Succinate)IBA 08/2021
1	Biocompatible Materials (Biomaterials)IBA 04/2021
1	taxifolinIBA 01/2021
1	Beclin-1IBA 01/2021
1	Biological ProductsIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	CathepsinsIBA 01/2021
1	CholesterolIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021

Therapy/Procedure

28	Therapeutics 02/2022 - 05/2013
4	Drug Therapy (Chemotherapy) 08/2021 - 04/2011
3	Immunotherapy 10/2021 - 01/2020
3	Photochemotherapy (Photodynamic Therapy) 01/2020 - 05/2017
2	Hematopoietic Stem Cell Transplantation 11/2020 - 10/2019
1	Drug Tapering 01/2022
1	Injections 12/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021